Third trimester of pregnancy definition

Third trimester of pregnancy means that portion of a pregnancy beginning with the twenty‑fifth week of gestation.
Sample 1Sample 2Sample 3
Third trimester of pregnancy means that portion of a pregnancy from and after the point in time when the fetus becomes viable.
Sample 1Sample 2
Third trimester of pregnancy means that portion of a pregnancy
Sample 1Sample 2Sample 3

Examples of Third trimester of pregnancy in a sentence

  • Active cancer treatment; (ii) Recent transplant (within the last twelve months); (iii) Scheduled surgery (within the next sixty days); (iv) Major surgery (within the previous sixty days); or (v) Third trimester of pregnancy.

  • Third trimester of pregnancy((; or(F) Language barrier)).If the employee is having premiums taken from payroll on a pretax basis, a plan change will not be approved if it would conflict with provisions of the salary reduction plan authorized under RCW 41.05.300.(b) Flexible spending account (FSA).

  • Third trimester of pregnancy((; or(vi) Language barrier)).If the employee is having premiums taken from payroll on a pretax basis, a plan change will not be approved if it would conflict with provisions of the salary reduction plan authorized under RCW 41.05.300.

  • Whilst we note the general agreement on the extent of effects we do note that there has been some disagreement between experts as to the effectiveness in future of mitigation measures which we will discuss below.

  • Where the processing centre is in Luxembourg, it may be hosted at a provider other than a credit institution or a support PFS, provided that it this provider does not act as operator.

  • EXHIBITS (ii) Recent transplant (within the last twelve months); (iii) Scheduled surgery (within the next sixty days); (iv) Major surgery (within the previous sixty days); or (v) Third trimester of pregnancy.

  • The SEBB program will consider but not limit its consideration to the following: • Active cancer treatment such as chemotherapy or radi- ation therapy for up to ninety days or until medically stable; • Transplant within the last twelve months; • Scheduled surgery within the next sixty days (elective procedures within the next sixty days do not qualify for con- tinuity of care); • Recent major surgery still within the postoperative period of up to eight weeks; or • Third trimester of pregnancy.

  • Drainage from oil filing points and any areas where fuels and lubricants are used will be connected to storm drains via a petrol interceptor. Dredging works will be avoided or minimized.

  • A) First trimester of pregnancy (first 3 months – 0-3 months) B) Second trimester of pregnancy (middle 3 months – 4-6 months) C) Third trimester of pregnancy (last 3 months – 7-9 months) D) Anytime during pregnancy3.

  • The SEBB program will consider but not limit its consideration to the following: • Active cancer treatment such as chemotherapy or radiation ther- apy for up to ninety days or until medically stable; • Transplant within the last twelve months; • Scheduled surgery within the next sixty days (elective proce- dures within the next sixty days do not qualify for continuity of care); • Recent major surgery still within the postoperative period of up to eight weeks; or • Third trimester of pregnancy.


More Definitions of Third trimester of pregnancy

Third trimester of pregnancy means that portion of a pregnancy beginning with the twenty-fifth week of gestation.
Sample 1Sample 2
Third trimester of pregnancy means that portion of a pregnancy from and after
Sample 1
Third trimester of pregnancy means that portion of a pregnancy after the twenty-third week of pregnancy and includes the entire period after the fetus is or may be viable.
Sample 1Sample 2

Related to Third trimester of pregnancy

  • Forced pregnancy means the unlawful confinement of a woman forcibly made pregnant, with the intent of affecting the ethnic composition of any population or carrying out other grave violations of international law. This definition shall not in any way be interpreted as affecting national laws relating to pregnancy;

  • Pregnancy means carrying a child, resulting childbirth, miscarriage and non-elective abortion. The Plan considers Pregnancy as a Sickness for the purpose of determining benefits.

  • Normal Pregnancy or “Childbirth” means a pregnancy or childbirth that is free of complications or problems.

  • Declared pregnant woman means a woman who has voluntarily informed the licensee or registrant, in writing, of her pregnancy and the estimated date of conception. The declaration remains in effect until the declared pregnant woman withdraws the declaration in writing or is no longer pregnant.

  • Sexual abuse means actual or threatened physical intrusion of a sexual nature, whether by force or under unequal or coercive conditions.

  • Complications of Pregnancy means conditions whose diagnoses are distinct from pregnancy but are adversely affected by pregnancy or are caused by pregnancy. These conditions include acute nephritis, nephrosis, cardiac decompensation, missed abortion and similar medical and surgical conditions of comparable severity. Complications of pregnancy also include nonelective cesarean section, ectopic pregnancy which is terminated and spontaneous termination of pregnancy, which occurs during a period of gestation in which a viable birth is not possible.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Pregnant or “pregnancy” means that female reproductive

  • Child abuse means any of the following acts committed in an educational setting by an employee or volunteer against a child:

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • Functional behavioral assessment means an individualized assessment of the student that results in a team hypothesis about the function of a student’s behavior and, as appropriate, recommendations for a behavior intervention plan.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Aquatic invasive species means any invasive, prohibited,

  • Genetic test means an analysis of human DNA, RNA, chromosomes, proteins, or metabolites, that detect genotypes, mutations, or chromosomal changes. The term “genetic test” does not mean an analysis of proteins or metabolites that does not detect genotypes, mutations, or chromosomal changes; or an analysis of proteins or metabolites that is directly related to a manifested disease, disorder, or pathological condition that could reasonably be detected by a health care professional with appropriate training and expertise in the field of medicine involved.

  • Acute toxicity means concurrent and delayed adverse effects that result from an acute exposure and occur within any short observation period, which begins when the exposure begins, may extend beyond the exposure period, and usually does not constitute a substantial portion of the life span of the organism.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.